AI
SAGE

AdvisorShares Investments’s Sage Therapeutics SAGE Stock Holding History

AdvisorShares Investments’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-83,642
Closed -$763K – 348
2025
Q2 		$763K Hold
83,642
– – 0.14% 82
2025
Q1 		$657K Buy
83,642
+35,842
+75% +$262K 0.13% 89
2024
Q4 		$260K Buy
47,800
+24,470
+105% +$150K 0.05% 207
2024
Q3 		$168K Buy
23,330
+7,300
+46% +$66.8K 0.03% 226
2024
Q2 		$177K Buy
16,030
+1,918
+14% +$24.6K 0.03% 229
2024
Q1 		$264K Buy
14,112
+750
+6% +$17.3K 0.04% 218
2023
Q4 		$290K Sell
13,362
-3,053
-19% -$60.5K 0.07% 211
2023
Q3 		$338K Buy
16,415
+11,188
+214% +$323K 0.09% 168
2023
Q2 		$246K Sell
5,227
-1,023
-16% -$50.9K 0.07% 190
2023
Q1 		$262K Sell
6,250
-889
-12% -$38.2K 0.08% 175
2022
Q4 		$272K Sell
7,139
-2,093
-23% -$79.9K 0.08% 202
2022
Q3 		$362K Buy
+9,232
New +$357K 0.1% 199

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AdvisorShares Investments's SAGE Position: Q3 2025 in Review

AdvisorShares Investments sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 83,642 shares — an estimated $763K sold.

AdvisorShares Investments first reported a position in SAGE in Q3 2022 and held it in 12 quarters. The position peaked at $763K in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • AdvisorShares Investments reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • AdvisorShares Investments sold 83,642 Sage Therapeutics shares in Q3 2025, an estimated $763K.
  • AdvisorShares Investments first reported a position in Sage Therapeutics in Q3 2022 and held it in 12 quarters.
  • AdvisorShares Investments's Sage Therapeutics position peaked at $763K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on AdvisorShares Investments's 13F filing for Q3 2025, filed 5 Nov 2025.